Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PIGS mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PIGS mRNA | affects expression | 21346803
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PIGS mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of PIGS mRNA | decreases expression | 18042831
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of PIGS mRNA | affects cotreatment|increases expression | 17183730
|
C041786 |
palm oil |
palm oil results in decreased expression of PIGS mRNA | decreases expression | 18042831
|
C066340 |
tolcapone |
tolcapone binds to PIGS protein | affects binding | 19783845
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of PIGS mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.82 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.17 | 19490988 |
MESH:D017109 |
Akathisia, Drug-Induced |
|
tolcapone |
6.67 | 11080934 |
MESH:D000544 |
Alzheimer Disease |
|
tolcapone |
3.32 | 20150427 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.61 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.76 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.19 | 15238619 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 17157402 15238991 18316065 18985861 19232924 20603192 18396377 16609825 19460635 18940202 17688650 18177632 18558336 17507914 18775368 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.18 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.54 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.26 | 20435547 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.05 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.05 | 16705839 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.11 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.11 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.78 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.09 | 19486331 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.94 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.94 | 18551238 |
MESH:D003866 |
Depressive Disorder |
|
tolcapone |
4.47 | 7768276 11224284 |
MESH:D003865 |
Depressive Disorder, Major |
|
tolcapone |
5.12 | 10440460 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.57 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.57 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
tolcapone |
9.57 | 19783845 16604736 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.57 | 19641884 1733752 |
MESH:D004409 |
Dyskinesia, Drug-Induced |
|
tolcapone |
5.77 | 11455177 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.62 | 18367378 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.31 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.46 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.29 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.04 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.80 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.60 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.40 | 3659116 |
MESH:D054908 |
Extensively Drug-Resistant Tuberculosis |
|
tolcapone |
6.32 | 19578428 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.59 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
14.59 | 17967931 18296743 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.59 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.26 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.41 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.73 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
9.73 | 18296743 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.20 | 17688650 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.83 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.87 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.17 | 10903974 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.93 | 16612254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.54 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.25 | 18457598 11836018 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.46 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.57 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.57 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.57 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 17596541 16294345 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.99 | 18296743 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.22 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.68 | 2876786 6135515 2876784 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.64 | 17228818 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.36 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.28 | 17596541 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.50 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.50 | 7678174 18551238 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.27 | 16359493 8888407 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.33 | 21332399 18457598 20518802 17217161 11836018 19632207 18674790 20132043 16723640 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.66 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.66 | 16049721 |
MESH:D010300 |
Parkinson Disease |
|
tolcapone |
3.67 | 8635184 11586115 1977408 20334432 9305320 9333106 9708959 11432539 9591521 9754991 20216409 19783845 11746615 8739811 18328768 11793426 19578428 16758261 7566641 10651109 17089403 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.17 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.92 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.44 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.75 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.75 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
10.75 | 1511512 3137016 14763951 17978042 11738929 11044598 16876388 15475178 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.92 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.61 | 17262798 |
MESH:D018088 |
Tuberculosis, Multidrug-Resistant |
|
tolcapone |
6.32 | 19578428 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.86 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.28 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.28 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.95 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.14 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.14 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D014820 |
Vitiligo |
|
tolcapone |
5.47 | 10573327 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.95 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |